190 related articles for article (PubMed ID: 30559191)
1. Cysteinyl leukotriene 2 receptor promotes endothelial permeability, tumor angiogenesis, and metastasis.
Duah E; Teegala LR; Kondeti V; Adapala RK; Keshamouni VG; Kanaoka Y; Austen KF; Thodeti CK; Paruchuri S
Proc Natl Acad Sci U S A; 2019 Jan; 116(1):199-204. PubMed ID: 30559191
[TBL] [Abstract][Full Text] [Related]
2. Multiple-site activation of the cysteinyl leukotriene receptor 2 is required for exacerbation of ischemia/reperfusion injury.
Ni NC; Ballantyne LL; Mewburn JD; Funk CD
Arterioscler Thromb Vasc Biol; 2014 Feb; 34(2):321-30. PubMed ID: 24285579
[TBL] [Abstract][Full Text] [Related]
3. A selective cysteinyl leukotriene receptor 2 antagonist blocks myocardial ischemia/reperfusion injury and vascular permeability in mice.
Ni NC; Yan D; Ballantyne LL; Barajas-Espinosa A; St Amand T; Pratt DA; Funk CD
J Pharmacol Exp Ther; 2011 Dec; 339(3):768-78. PubMed ID: 21903747
[TBL] [Abstract][Full Text] [Related]
4. HAMI 3379, a CysLT2 receptor antagonist, attenuates ischemia-like neuronal injury by inhibiting microglial activation.
Zhang XY; Wang XR; Xu DM; Yu SY; Shi QJ; Zhang LH; Chen L; Fang SH; Lu YB; Zhang WP; Wei EQ
J Pharmacol Exp Ther; 2013 Aug; 346(2):328-41. PubMed ID: 23750020
[TBL] [Abstract][Full Text] [Related]
5. Identification of GPR99 protein as a potential third cysteinyl leukotriene receptor with a preference for leukotriene E4 ligand.
Kanaoka Y; Maekawa A; Austen KF
J Biol Chem; 2013 Apr; 288(16):10967-72. PubMed ID: 23504326
[TBL] [Abstract][Full Text] [Related]
6. Autocrine activity of cysteinyl leukotrienes in human vascular endothelial cells: Signaling through the CysLT₂ receptor.
Capra V; Carnini C; Accomazzo MR; Di Gennaro A; Fiumicelli M; Borroni E; Brivio I; Buccellati C; Mangano P; Carnevali S; Rovati G; Sala A
Prostaglandins Other Lipid Mediat; 2015 Jul; 120():115-25. PubMed ID: 25839425
[TBL] [Abstract][Full Text] [Related]
7. DNA Methylation and Gene Expression of the Cysteinyl Leukotriene Receptors as a Prognostic and Metastatic Factor for Colorectal Cancer Patients.
Ghatak S; Satapathy SR; Sjölander A
Int J Mol Sci; 2023 Feb; 24(4):. PubMed ID: 36834820
[TBL] [Abstract][Full Text] [Related]
8. [Effects of cysteinyl leukotriene receptors on phagocytosis of mouse microglial cells].
Wang X; Lu Y; Zhang W; Wei E; Fang S
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2018 Jan; 47(1):10-18. PubMed ID: 30146806
[TBL] [Abstract][Full Text] [Related]
9. HAMI 3379, a CysLT2R antagonist, dose- and time-dependently attenuates brain injury and inhibits microglial inflammation after focal cerebral ischemia in rats.
Shi QJ; Wang H; Liu ZX; Fang SH; Song XM; Lu YB; Zhang WP; Sa XY; Ying HZ; Wei EQ
Neuroscience; 2015 Apr; 291():53-69. PubMed ID: 25681271
[TBL] [Abstract][Full Text] [Related]
10. Characterization of cysteinyl leukotriene-related receptors and their interactions in a mouse model of asthma.
Trinh HKT; Suh DH; Nguyen TVT; Choi Y; Park HS; Shin YS
Prostaglandins Leukot Essent Fatty Acids; 2019 Feb; 141():17-23. PubMed ID: 30661601
[TBL] [Abstract][Full Text] [Related]
11. Directed vascular expression of human cysteinyl leukotriene 2 receptor modulates endothelial permeability and systemic blood pressure.
Hui Y; Cheng Y; Smalera I; Jian W; Goldhahn L; Fitzgerald GA; Funk CD
Circulation; 2004 Nov; 110(21):3360-6. PubMed ID: 15545522
[TBL] [Abstract][Full Text] [Related]
12. Agonist- and T(H)2 cytokine-induced up-regulation of cysteinyl leukotriene receptor messenger RNA in human monocytes.
Shirasaki H; Seki N; Fujita M; Kikuchi M; Kanaizumi E; Watanabe K; Himi T
Ann Allergy Asthma Immunol; 2007 Oct; 99(4):340-7. PubMed ID: 17941281
[TBL] [Abstract][Full Text] [Related]
13. CysLT2 receptor mediates lipopolysaccharide-induced microglial inflammation and consequent neurotoxicity in vitro.
Chen L; Yang Y; Li CT; Zhang SR; Zheng W; Wei EQ; Zhang LH
Brain Res; 2015 Oct; 1624():433-445. PubMed ID: 26282348
[TBL] [Abstract][Full Text] [Related]
14. Neutralization of leukotriene C4 and D4 activity by monoclonal and single-chain antibodies.
Kawakami Y; Hirano S; Kinoshita M; Otsuki A; Suzuki-Yamamoto T; Suzuki M; Kimoto M; Sasabe S; Fukushima M; Kishimoto K; Izumi T; Oga T; Narumiya S; Sugahara M; Miyano M; Yamamoto S; Takahashi Y
Biochim Biophys Acta; 2014 Jun; 1840(6):1625-33. PubMed ID: 24361619
[TBL] [Abstract][Full Text] [Related]
15. Interferon-gamma up-regulates expression of cysteinyl leukotriene type 2 receptors on eosinophils in asthmatic patients.
Fujii M; Tanaka H; Abe S
Chest; 2005 Nov; 128(5):3148-55. PubMed ID: 16304255
[TBL] [Abstract][Full Text] [Related]
16. Dominant expression of the CysLT2 receptor accounts for calcium signaling by cysteinyl leukotrienes in human umbilical vein endothelial cells.
Sjöström M; Johansson AS; Schröder O; Qiu H; Palmblad J; Haeggström JZ
Arterioscler Thromb Vasc Biol; 2003 Aug; 23(8):e37-41. PubMed ID: 12816881
[TBL] [Abstract][Full Text] [Related]
17. Expression of the type 2 receptor for cysteinyl leukotrienes (CysLT2R) by human mast cells: Functional distinction from CysLT1R.
Mellor EA; Frank N; Soler D; Hodge MR; Lora JM; Austen KF; Boyce JA
Proc Natl Acad Sci U S A; 2003 Sep; 100(20):11589-93. PubMed ID: 13679572
[TBL] [Abstract][Full Text] [Related]
18. [Expression and distribution of cysteinyl leukotriene receptors CysLT1R and CysLT2R, and GPR17 in brain of Parkinson disease model mice].
Wang H; Shi Q; Shi W; Zhang X; Wang X; Zhang L; Fang S; Lu Y; Zhang W; Wei E
Zhejiang Da Xue Xue Bao Yi Xue Ban; 2013 Jan; 42(1):52-60. PubMed ID: 23505108
[TBL] [Abstract][Full Text] [Related]
19. Mechanosensitive TRPV4 channels stabilize VE-cadherin junctions to regulate tumor vascular integrity and metastasis.
Cappelli HC; Kanugula AK; Adapala RK; Amin V; Sharma P; Midha P; Paruchuri S; Thodeti CK
Cancer Lett; 2019 Feb; 442():15-20. PubMed ID: 30401632
[TBL] [Abstract][Full Text] [Related]
20. Type 2 Cysteinyl Leukotriene Receptors Drive IL-33-Dependent Type 2 Immunopathology and Aspirin Sensitivity.
Liu T; Barrett NA; Kanaoka Y; Yoshimoto E; Garofalo D; Cirka H; Feng C; Boyce JA
J Immunol; 2018 Feb; 200(3):915-927. PubMed ID: 29282304
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
